Overview
- 98 inspections across 89 sites are on record.
- 217 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-03-22.
At a glance
Inspections
98
Sites
89
Observations
217
Career since
Jun 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Invitrx Therapeutics Inc. | 22 Mar 2022 | Biologics | View 483 → |
| Biomat USA, Inc. | 13 Feb 2020 | Biologics | |
| Stratus BioSystems, LLC | 28 Feb 2019 | Biologics | View 483 → |
| American National Red Cross (The) | 10 Jul 2018 | Biologics | |
| Theranos, Inc. | 18 Aug 2016 | Medical Devices & Rad Health |
Sites inspected
Invitrx Therapeutics Inc.Lake Forest, United States1 insp.
Biomat USA, Inc.Orem, United States1 insp.
Stratus BioSystems, LLCGrapevine, United States1 insp.
American National Red Cross (The)Pleasant Hill, United States1 insp.
Theranos, Inc.Palo Alto, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Seyyida Saterfield3 shared
Shelley H Beausoleil2 shared
Laurissa S Flowers1 shared
Garrad R Poole1 shared
Emily B Camire1 shared
Lauren M Lilly1 shared
Elmina E Akwo1 shared
Bryce A May1 shared
Ian A Pilcher1 shared
Hoimay Chan1 shared
Full investigator report
Get the verbatim findings behind Aneel K Sandhu's 217 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site